신장 질환 시장 조사 – 규모, 점유율, 개발 및 미래 범위 2031

  • Report Code : TIPRE00014589
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 215
Buy Now

신장질환 시장 규모는 2019년 811억 2,811만 달러에서 2027년 1억 334억 4,471만 달러로 성장할 것으로 예상됩니다. 2020년부터 2027년까지 연평균 성장률(CAGR) 6.5%로 성장할 것으로 예상됩니다.

  ;

정책 입안자들은 의료는 물론 의약품에 대한 공평하고 저렴하며 지속 가능한 접근을 충족하기 위해 적절한 제약 정책 옵션 조합이 구현되도록 해야 합니다. 세계보건기구(WHO)는 필수 의약품 목록의 개념과 보편적 건강 보장(UHC) 접근 방식을 포함하여 정책 입안자가 적절한 정책을 개발하도록 지원하기 위한 다양한 전략을 계획했습니다. 더욱이, 진보된 UHC 및 사회 보호 시스템을 갖춘 유럽 국가들은 시민에게 다양한 중요 의약품을 무료 또는 할인된 비용으로 제공하려는 의약품 가격 책정 및 상환 시스템을 개발했습니다. 예를 들어, 아르메니아는 결핵, 정신 건강 질환, 당뇨병, 만성 신부전과 같은 특정 질병에 대한 의약품에 대해 100% 상환을 보장합니다.

2019년 5월, 혈중 칼륨 농도가 높은(고칼륨혈증) 치료에 사용되는 처방약인 VELTASSA가 AMNOG 절차를 완료하여 독일에서 급여를 확보했습니다. (가격협상 및 중재과정) 또한 핀란드, 오스트리아, 포르투갈, 스페인, 벨기에에서는 급여가 확보됐고, 영국 국립보건의료연구소(National Institute for Health and Care Excellence)로부터도 호평을 받았다. 또한 2019년 말에는 스웨덴, 노르웨이, 덴마크, 벨기에, 독일, 스페인, 네덜란드, 오스트리아에서 VELTASSA가 출시되었습니다. 게다가 2018년 Vifor Pharma는 일본에서 VELTASSA의 규제 및 상환 승인 과정을 촉진하기 위해 Zeria Pharmaceutical Co., Ltd.와 라이센스 계약을 발표했습니다. 또한, 2019년 12월 중국 국가의료안전국(NHSA)은 록사두스타트를 업데이트된 국가 상환 의약품 목록(NRDL)에 포함시켰습니다. 록사두스타트(Roxadustat)라는 약물은 CKD(만성 신장 질환)의 빈혈 치료를 위한 NRDL에 포함되어 있습니다. 이러한 수익성 있는 상환 정책은 예측 기간 동안 시장 성장을 가속화할 가능성이 높습니다.

신장 질환에 대한 수익성 있는 지역 시장


시장 통찰력

신장 질환으로 이어지는 만성 질환의 높은 유병률

만성 신장 질환(CKD)은 전 세계적으로 10명 중 1명에게 영향을 미치는 흔하고 생명을 위협하는 질환입니다. 고혈압과 당뇨병은 2015년부터 2017년까지 신부전 사례의 75%에서 두 가지 주요 원인이었습니다. 또한 2020년 국립신장재단(National Kidney Foundation)에서 발표한 연구에 따르면 20세 이상의 당뇨병 인구 중 약 35.0%가 만성 신부전으로 발전할 것으로 나타났습니다. 일정 기간 동안의 신장 질환.

국립신장재단(National Kidney Foundation Inc.)이 발표한 자료에 따르면 2020년에는 만성콩팥병으로 인한 사망자가 전립선암이나 유방암보다 더 많을 가능성이 높다. 이는 사람들 사이에서 잘 인식되지 않는 응급 건강 상태입니다. 미국 성인 3명 중 1명(약 8천만 명)이 만성콩팥병으로 인한 위험에 처해 있습니다.

미국 질병통제예방센터(CDC)에서 발표한 추정에 따르면 2020년에는 당뇨병이 있는 성인 3명 중 1명, 고혈압이 있는 성인 5명 중 1명이 만성 신장 질환을 앓고 있을 수 있습니다. 미국 당뇨병 협회(American Diabetes Association)에 따르면 2015년 미국 내 당뇨병 환자 수는 3,030만 명이었습니다. CDC에 따르면 2014년 미국에서는 약 118,000명이 말기신장질환 치료를 시작했으며, 이 질환에 대한 인식이 높아짐에 따라 이 치료를 받는 사람도 늘어날 것으로 예상된다. 더욱이 CDC는 신장 손상을 앓고 있는 사람들의 약 96%가 만성 신장 질환을 앓고 있다는 사실을 모르고 있다고 밝혔는데, 이는 신장 질환 시장의 기본 시장 전망을 나타냅니다. 이러한 요인들은 예측 기간 동안 시장 성장을 강화할 것으로 예상됩니다.


제품 유형 통찰력

제품 유형에 따라 신장 질환 시장은 진단과 치료로 분류됩니다. 2019년에는 진단 부문이 시장에서 가장 큰 점유율을 차지했습니다. 이 부문의 성장은 혈액 내 검사, 소변 검사 및 다양한 영상 절차의 증가에 기인합니다.

제품별 글로벌 신장 질환 시장– 2019년 및 2027년


최종 사용자 통계

최종 사용자 기준, 전 세계 신장 질환 시장 병원, 진단검사실 등으로 구분됩니다. 2019년에는 병원 부문이 시장의 주요 점유율을 차지했으며 동일한 부문이 예측 기간 동안 시장에서 가장 높은 CAGR을 기록할 것으로 예상됩니다.

전략적 통찰력

제품 출시 및 승인은 기업이 증가하는 소비자 수요를 충족하기 위해 글로벌 입지와 제품 포트폴리오를 확장하기 위해 일반적으로 채택하는 전략입니다. 신장 질환 시장 참여자들은 전 세계적으로 고객 기반을 확대하기 위해 협력 전략을 채택했으며, 이를 통해 전 세계적으로 브랜드 이름을 유지할 수도 있습니다.

신장 질환 시장– 제품 유형별

  •      진단
    •     혈액 검사
    •     소변 검사
    •     이미징 테스트
    •     기타
  •   치료
    •   약물 종류
      •   ACE 억제제
      •   안지오텐신-II 수용체 차단제
      •   이뇨제
      •   기타

신장질환 시장– 최종 사용자에 의한

  •      병원
  •      진단 실험실
  •      기타

신장질환 시장 – 지역별

  • 북미
    • 미국
    • 캐나다
    • 멕시코
  • < li>유럽
    • 프랑스
    • 독일
    • 이탈리아
    • 영국
    • 스페인
    • 나머지 유럽
  • 아시아 태평양(APAC)
    • 중국
    • 인도
    • 대한민국
    • 일본
    • 호주
    • 아시아 태평양 지역
  • 중동 및 아프리카(MEA)
      < li>남아프리카공화국
    • 사우디아라비아
    • UAE
    • 중동 및 아프리카 나머지 지역
  • 중남미
    • 브라질
    • 아르헨티나
    • 남미 나머지 지역

  ;

회사 프로필

  • 애보트
  • F. Hoffmann-La Roche Ltd.
  • AbbVie's Inc.
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • GlaxoSmithKline plc
  • Amgen Inc.
  • Sysmex Corp.
  • Fresenius Medical Care SE & KGaA
  • Siemens Healthineers AG
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is kidney disease?

Renal disease, commonly known as chronic kidney failure, is characterised by a progressive loss of kidney function. Wastes and excess fluids are removed from the circulation by the kidneys, which are then excreted in urine. Advanced chronic renal disease can result in harmful accumulations of fluid, electrolytes, and wastes in the body. These issues may develop gradually over a lengthy period of time. Diabetes, high blood pressure, and other illnesses can lead to chronic kidney disease. Early detection and treatment can typically prevent the progression of chronic renal disease. When kidney disease continues, it can lead to renal failure, which necessitates dialysis or a kidney transplant. Chronic renal disease treatment focuses on delaying the progression of kidney damage, usually by addressing the underlying cause. Controlling the cause, however, may not be enough to prevent kidney disease from developing. Without mechanical filtering (dialysis) or a kidney transplant, chronic kidney disease can proceed to end-stage kidney failure, which is fatal.

What are the driving factors for the kidney diseases market across the globe?

Key factors that are driving the growth of this market are high prevalence of chronic diseases leading to kidney diseases and favorable reimbursement policy for kidney disease treatments are expected to boost the market growth for the kidney diseases over the years.

What is the market CAGR value of kidney diseases market during forecast period?

The CAGR value of the kidney diseases market during the forecasted period of 2020-2027 is 6.5%.

Which product type led the kidney diseases market?

The diagnosis segment held the largest share of the market in the global kidney diseases market and held the largest market share of 56.80% in 2019.

Which end user held the largest share in the kidney diseases market?

The hospitals segment dominated the global kidney diseases market and held the largest market share of 47.35% in 2019.

Who are the key players in the kidney diseases market?

The kidney diseases market majorly consists of the players such as Abbott, Siemens AG, Amgen Inc., Sysmex Corporation, GlaxoSmithKline plc., Teva Pharmaceutical Industries Ltd, Fresenius Medical Care, F. Hoffmann-La Roche Ltd, AbbVie Inc., and Pfizer among others.

The List of Companies - Kidney Disease Market

  1. Abbott
  2. F. Hoffmann-La Roche Ltd.
  3. AbbVie's Inc.
  4. Pfizer Inc.
  5. Teva Pharmaceutical Industries Ltd.
  6. GlaxoSmithKline plc
  7. Amgen Inc.
  8. Sysmex Corp.
  9. Fresenius Medical Care SE & Co. KGaA
  10. Siemens Healthineers AG

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports